Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Shahrokh Shariat

Showing results (31-40 of 93) with videos related to

Pageof 10
Sort By:
European Urology Oncology|May 18, 2019
Cytoreductive Radical Prostatectomy in Men with Prostate Cancer and Skeletal MetastasesAxel Heidenreich, Nicola Fossati, David Pfister, et al.
Oncotarget|April 18, 2018
Analysis of hematological parameters as prognostic markers for toxicity and survival of <sup>223</sup>Radium treatmentAsha Leisser, Marzieh Nejabat, Markus Hartenbach, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|September 21, 2023
Antihormonal-Treatment Status Affects <sup>68</sup>Ga-PSMA-HBED-CC PET Biodistribution in Patients with Prostate CancerKilian Kluge, David Haberl, Holger Einspieler, et al.
World Journal of Urology|September 15, 2019
Evaluation of the prognostic role of co-morbidities on disease outcome in renal cell carcinoma patientsJohannes Heide, Silvia Ribback, Tobias Klatte, et al.
European Radiology|November 15, 2017
3D T2-weighted imaging to shorten multiparametric prostate MRI protocolsStephan H Polanec, Mathias Lazar, Georg J Wengert, et al.
Urology|November 29, 2008
Sex hormone-binding globulin: a novel marker for nodal metastases prediction in prostate cancer patients undergoing extended pelvic lymph node dissectionAndrea Salonia, Alberto Briganti, Andrea Gallina, et al.
World Journal of Urology|September 27, 2015
Multiparametric MRI of the prostate at 3 T: limited value of 3D (1)H-MR spectroscopy as a fourth parameterStephan H Polanec, Katja Pinker-Domenig, Peter Brader, et al.
European Urology|December 13, 2016
Reply to Harry Herr's Letter to the Editor re: Marko Babjuk, Andreas Böhle, Maximilian Burger, et al. EAU Guidelines on Non-muscle-invasive Urothelial Carcinoma of the Bladder: Update 2016. Eur Urol 2017;71:447-61Marko Babjuk, Maximilian Burger, Eva Compérat, et al.
European Journal of Nuclear Medicine and Molecular Imaging|May 1, 2024
Comparison of discovery rates and prognostic utility of [<sup>68</sup>Ga]Ga-PSMA-11 PET/CT and circulating tumor DNA in prostate cancer-a cross-sectional studyKilian Kluge, Holger Einspieler, David Haberl, et al.
European Journal of Nuclear Medicine and Molecular Imaging|November 30, 2019
Clinical outcome of standardized <sup>177</sup>Lu-PSMA-617 therapy in metastatic prostate cancer patients receiving 7400 MBq every 4 weeksSazan Rasul, Marcus Hacker, Elisabeth Kretschmer-Chott, et al.
Pageof 10

Showing results (31-40 of 93) with videos related to

Sort By:
Pageof 10
European Urology Oncology|May 18, 2019
Cytoreductive Radical Prostatectomy in Men with Prostate Cancer and Skeletal MetastasesAxel Heidenreich, Nicola Fossati, David Pfister, et al.
Oncotarget|April 18, 2018
Analysis of hematological parameters as prognostic markers for toxicity and survival of <sup>223</sup>Radium treatmentAsha Leisser, Marzieh Nejabat, Markus Hartenbach, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|September 21, 2023
Antihormonal-Treatment Status Affects <sup>68</sup>Ga-PSMA-HBED-CC PET Biodistribution in Patients with Prostate CancerKilian Kluge, David Haberl, Holger Einspieler, et al.
World Journal of Urology|September 15, 2019
Evaluation of the prognostic role of co-morbidities on disease outcome in renal cell carcinoma patientsJohannes Heide, Silvia Ribback, Tobias Klatte, et al.
European Radiology|November 15, 2017
3D T2-weighted imaging to shorten multiparametric prostate MRI protocolsStephan H Polanec, Mathias Lazar, Georg J Wengert, et al.
Urology|November 29, 2008
Sex hormone-binding globulin: a novel marker for nodal metastases prediction in prostate cancer patients undergoing extended pelvic lymph node dissectionAndrea Salonia, Alberto Briganti, Andrea Gallina, et al.
World Journal of Urology|September 27, 2015
Multiparametric MRI of the prostate at 3 T: limited value of 3D (1)H-MR spectroscopy as a fourth parameterStephan H Polanec, Katja Pinker-Domenig, Peter Brader, et al.
European Urology|December 13, 2016
Reply to Harry Herr's Letter to the Editor re: Marko Babjuk, Andreas Böhle, Maximilian Burger, et al. EAU Guidelines on Non-muscle-invasive Urothelial Carcinoma of the Bladder: Update 2016. Eur Urol 2017;71:447-61Marko Babjuk, Maximilian Burger, Eva Compérat, et al.
European Journal of Nuclear Medicine and Molecular Imaging|May 1, 2024
Comparison of discovery rates and prognostic utility of [<sup>68</sup>Ga]Ga-PSMA-11 PET/CT and circulating tumor DNA in prostate cancer-a cross-sectional studyKilian Kluge, Holger Einspieler, David Haberl, et al.
European Journal of Nuclear Medicine and Molecular Imaging|November 30, 2019
Clinical outcome of standardized <sup>177</sup>Lu-PSMA-617 therapy in metastatic prostate cancer patients receiving 7400 MBq every 4 weeksSazan Rasul, Marcus Hacker, Elisabeth Kretschmer-Chott, et al.
Pageof 10